Memorial Sloan-Kettering Cancer Center   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: New York NY United States (1884)

Organization Overview

First Clinical Trial
2016
NCT03371420
First Marketed Drug
2016
fludeoxyglucose f-18
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Memorial Hospital for Cancer and Allied Diseases | Memorial Sloan Kettering Cancer Center | Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA | Memorial Sloan Kettering Cancer Center (MSKCC) | Memorial Sloan Kettering Cancer Centre, New York City, United States | Memorial Sloan Kettering, USA | MEM SLOAN-KETTERING | MSKCC